A reader questions whether insurers’ practice of promoting medications has undermined physicians’ ability to provide quality patient care
The ACR President Joseph Flood, MD, Reviews 2014 in Rheumatology
Information technology an overarching theme of this year’s work
New Assay Aids In Evaluating Metabolic Effects of Glucocorticoids
Test measures efficacy of compounds for treating arthritis and their effect on glucose kinetics
New Research Points to Possible Future Treatment Option for Alopecia Areata
Topical application of protein tyrosine kinase inhibitors shown to reverse mouse model of the disease
Home Microbiome Project Pegs People as Primary Bacteria Vectors
Research suggests humans harbor microbial fingerprint that can be transferred to new indoor spaces
Better Blood Pressure Screening Needed to Manage Cardiovascular Disease Risk in Rheumatoid Arthritis
Study finds hypertensive patients with RA less likely to be diagnosed with high blood pressure than non-RA patients
American Medical Association House of Delegates Annual Meeting Update
AMA delegation chair Gary L. Bryant, MD, outlines AMA’s progress with ongoing initiatives, new resolutions submitted by the ACR
Advocate for Rheumatology Issues During Election Season
The ACR encourages members to meet with elected officials during Congress’ fall recess
Rheumatology Research Foundation’s Annual Investigators’ Meeting Spotlights Latest Findings
Groundbreaking research in treatments for rheumatoid arthritis, inflammatory disease discussed at Foundation’s celebrated event
The 2014 ACR/ARHP Annual Meeting Must-See Pre-Meeting Courses
Courses on microbiome in rheumatic diseases, patient-centered outcomes are highlights
- « Previous Page
- 1
- …
- 211
- 212
- 213
- 214
- 215
- …
- 300
- Next Page »